Cargando…
Optimizing Blood Stem Cell Transplants Through Cellular Engineering
Haematopoietic stem cell transplants (HSCT) are used in the treatment of blood cancers, autoimmune diseases, and metabolic disorders. Over 1.5 million transplants have been performed around the world thus far. In an attempt to enhance the efficacy of the cells used for transplantation, efforts are u...
Autores principales: | Soh, Krystal Valerie Qian Ying, Hwang, William Ying Khee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia-Pacific Blood and Marrow Transplantation Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847292/ https://www.ncbi.nlm.nih.gov/pubmed/36714264 http://dx.doi.org/10.31547/bct-2021-008 |
Ejemplares similares
-
Expansion of Haematopoietic Stem and Progenitor Cells: Paving the Way for Next-Generation Haematopoietic Stem Cell Transplantation
por: Bari, Sudipto, et al.
Publicado: (2019) -
Editorial: Recent Developments in Haploidentical Hematopoietic Cell Transplantation: Therapy and Complications
por: Chang, Ying-Jun, et al.
Publicado: (2021) -
Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
por: Ong, Shin-Yeu, et al.
Publicado: (2015) -
Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature
por: Mohammadi, Saeed, et al.
Publicado: (2017) -
Stem cell transplantation during cancer
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)